Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial

Cite this paper

@inproceedings{Chetchotisakd2014Trimethoprimsulfamethoxazole, title={Trimethoprim-sulfamethoxazole versus trimethoprim-sulfamethoxazole plus doxycycline as oral eradicative treatment for melioidosis (MERTH): a multicentre, double-blind, non-inferiority, randomised controlled trial}, author={Ploenchan Chetchotisakd and Wirongrong Chierakul and Wipada Chaowagul and Siriluck Anunnatsiri and Kriangsak Phimda and Piroon Mootsikapun and Seksan Chaisuksant and Jiraporn Pilaikul and Bandit Thinkhamrop and Sunchai Phiphitaporn and Wattanachai Susaengrat and Chalongchai Toondee and Surasakdi Wongrattanacheewin and Vanaporn Wuthiekanun and Narisara Chantratita and Janjira Thaipadungpanit and Nicholas P J Day and Direk Limmathurotsakul and Sharon J Peacock}, booktitle={The Lancet}, year={2014} }